We aimed to explore the effect of YAP1 in tumor aggressiveness and immune evasion in breast invasive carcinoma and metastatic breast cancer in the context of Interleukin‐18 (IL‐18) in silico. This evidence concerns the gene IL18 and invasive breast carcinoma.